Risk-reducing surgery in hereditary gynecological cancer: Clinical applications in Lynch syndrome and hereditary breast and ovarian cancer

Molecular and Clinical Oncology
Masataka AdachiDaisuke Aoki

Abstract

Risk-reducing surgery (RRS) is defined as a prophylactic approach with removal of organs at high risk of developing cancer, which is performed in cases without lesions or absence of clinically significant lesions. Hereditary gynecological cancers for which RRS is performed include hereditary breast and ovarian cancer (HBOC) and Lynch syndrome. For HBOC, RRS in the United States (US) is recommended for women with mutations in the breast cancer susceptibility (BRCA)1 and BRCA2 genes and bilateral salpingo-oophorectomy (BSO) is generally performed. This procedure may reduce the risk of breast, ovarian, Fallopian tube and primary peritoneal cancer, although ovarian deficiency symptoms occur postoperatively. For Lynch syndrome, RRS in the US is considered for postmenopausal women or for women who do not desire to bear children and BSO and hysterectomy are usually performed. This approach may reduce the risk of endometrial and ovarian cancer, although ovarian deficiency symptoms also occur. For RRS, there are several issues that must be addressed to reduce the risk of cancer development in patients with HBOC or Lynch syndrome. To the best of our knowledge, this is the first review to discuss RRS with a focus on hereditary gynecologic...Continue Reading

References

Feb 1, 1995·Obstetrics and Gynecology·D GradyD Petitti
Jan 1, 1997·Human Molecular Genetics·M G DunlopB Vogelstein
May 15, 1997·The New England Journal of Medicine·J P StruewingM A Tucker
Apr 3, 1999·International Journal of Cancer. Journal International Du Cancer·M AarnioH J Järvinen
May 12, 2000·JAMA : the Journal of the American Medical Association·J BoydW J Hoskins
Sep 5, 2001·Gynecologic Oncology·P WatsonUNKNOWN International Collaborative Group on HNPCC
May 25, 2002·The New England Journal of Medicine·Noah D KauffKenneth Offit
Oct 25, 2003·Science·Mary-Claire KingUNKNOWN New York Breast Cancer Study Group
Dec 12, 2003·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Bruce A WernessM Steven Piver
Feb 10, 2004·Gynecologic Oncology·Ofer LavieUzi Beller
Apr 15, 2004·JAMA : the Journal of the American Medical Association·Garnet L AndersonUNKNOWN Women's Health Initiative Steering Committee
May 4, 2005·Lancet·Valerie BeralUNKNOWN Million Women Study Collaborators
Sep 2, 2005·Familial Cancer·Karen H Lu, Russell R Broaddus
Sep 22, 2005·Journal of the National Cancer Institute·Noah D KauffKenneth Offit
Oct 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Timothy R RebbeckUNKNOWN PROSE Study Group
Jan 13, 2006·The American Journal of Gastroenterology·Keiji HirataUNKNOWN HNPCC registry and genetic testing project of the Japanese Society for Cancer of the Colon and Rectum (JSCCR)
Jan 20, 2006·The New England Journal of Medicine·Kathleen M SchmelerKaren H Lu
Jan 20, 2006·The New England Journal of Medicine·Kenneth Offit, Noah D Kauff
Feb 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard R BarakatUNKNOWN Gynecologic Oncology Group Study
Feb 14, 2006·Gynecologic Oncology·Jeannine A VillellaKerry Rodabaugh
Mar 22, 2006·Annals of Internal Medicine·Kristin AndersonVictor R Grann
May 4, 2006·JAMA : the Journal of the American Medical Association·Heidi D NelsonLinda Humphrey
Jul 13, 2006·JAMA : the Journal of the American Medical Association·Amy FinchUNKNOWN Hereditary Ovarian Cancer Clinical Study Group
Sep 12, 2006·Gynecologic Oncology·Mario E BeinerUNKNOWN Hereditary Ovarian Cancer Clinical Study Group
Sep 28, 2006·JAMA : the Journal of the American Medical Association·Noralane M LindorNancy Press
Oct 5, 2006·Journal of the National Cancer Institute·James V LaceyPatricia Hartge
Jul 3, 2007·Obstetrics and Gynecology·Lee-may ChenAaron B Caughey
Jul 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Noah D Kauff, Richard R Barakat
Oct 9, 2007·Seminars in Oncology·Siobhan M Kehoe, Noah D Kauff
Sep 25, 2008·Journal of the National Cancer Institute·Andrea EisenUNKNOWN Hereditary Breast Cancer Clinical Study Group
Dec 17, 2008·Cancer Control : Journal of the Moffitt Cancer Center·Larissa A MeyerKaren H Lu
Jan 15, 2009·Journal of the National Cancer Institute·Timothy R RebbeckSusan M Domchek
Apr 30, 2010·Obstetrics and Gynecology·Kathleen M SchmelerKaren H Lu
Feb 26, 2010·World Journal of Surgery·Ava KwongCatherine L Y Choi
May 27, 2010·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·John A Eden
Sep 3, 2010·JAMA : the Journal of the American Medical Association·Susan M DomchekTimothy R Rebbeck

❮ Previous
Next ❯

Citations

Nov 3, 2020·Clinical Obstetrics and Gynecology·Meredith HumphreysJoseph M Letourneau

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.